Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 27 2024
0mins
Should l Buy SES?
Source: Benzinga
Evaxion Biotech's Patent Application: Shares of Evaxion Biotech A/S surged 62% in pre-market trading after the company applied for a patent for vaccines targeting Neisseria gonorrhoeae.
Market Movements: Several stocks experienced significant gains and losses in pre-market trading, with Intrusion Inc. gaining 177% and Viracta Therapeutics falling 21.8%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SES?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SES
Wall Street analysts forecast SES stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.090
Low
4.00
Averages
4.00
High
4.00
Current: 1.090
Low
4.00
Averages
4.00
High
4.00
About SES
SES AI Corporation is a battery manufacturing company. The Company is a developer and manufacturer of high-performance, artificial intelligence (AI)-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility, drones, robotics, Battery Energy Storage Systems and other applications. It utilizes AI across the spectrum of its business, from research and development; materials sourcing; cell design; engineering and manufacturing; to battery health and safety monitoring. The Company's differentiated battery technology is designed to combine the high energy density of Li-Metal with the manufacturability of conventional Li-ion batteries. It produces large 50 Amp-hour (Ah) and 100Ah B-sample Li-Metal battery cells for EVs. Its AI programs fall under three major categories: AI for Science, AI for Manufacturing, and AI for Safety. The Company also specializes in premium energy storage systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Deadline Reminder: ClaimsFiler informs investors that the deadline to file lead plaintiff applications in the securities class action against SES AI Corporation is June 26, 2026, affecting those who purchased securities between January 29, 2025, and March 4, 2026, which may impact their claims rights.
- Legal Allegations: SES and certain executives are accused of failing to disclose material information during the class period, violating federal securities laws, including exaggerating business outlooks and creating the appearance of revenue, which could undermine investor confidence in the company.
- Financial Impact: SES AI faced significant logistics constraints in Q4 2025 that materially impacted revenue, despite optimistic growth statements, raising serious doubts about 2026 growth prospects, ultimately leading to weaker-than-expected revenue guidance for 2026.
- Legal Support: Investors can access free information through ClaimsFiler to learn how to submit claims and connect with Kahn Swick & Foti, LLC for legal options, assisting investors in protecting their rights.
See More
- Lawsuit Background: Glancy Prongay Wolke & Rotter LLP reminds investors that those who purchased SES AI Corporation (NYSE:SES) securities between January 29, 2025, and March 4, 2026, can file a lead plaintiff motion by June 26, 2026, due to misleading statements that led to investor losses.
- Declining Financial Performance: On March 4, 2026, SES AI announced fourth-quarter and full-year 2025 financial results, revealing 2026 revenue guidance below market expectations, which caused the stock price to plummet by 36.8% to $1.08 per share the following day, severely impacting investor confidence.
- Allegations Details: The lawsuit alleges that SES AI failed to disclose significant adverse facts about its business, operations, and prospects throughout the class period, including overstating expected results from deals and being affected by material logistics constraints that questioned its growth prospects.
- Opportunity for Legal Action: Investors who acquired SES AI securities during the class period may apply to become lead plaintiffs before the deadline to pursue claims under federal securities laws, highlighting concerns over corporate governance and transparency.
See More
- SES AI Lawsuit Overview: SES AI Corporation faces a class action lawsuit for making false statements during the period from February 15, 2024, to August 14, 2025, with a lead plaintiff deadline of June 23, 2026, urging investors to act promptly to avoid losing their rights to claim.
- FS KKR Capital Issues: FS KKR Capital Corp. is accused of overstating the effectiveness of its portfolio restructuring efforts from May 8, 2024, to February 25, 2026, with a lead plaintiff deadline of July 6, 2026, highlighting the importance of timely participation to secure potential claims.
- Graphic Packaging Lawsuit Details: Graphic Packaging Holding Company is facing a class action for failing to disclose significant inventory management issues and reduced demand from February 4, 2025, to February 2, 2026, with a lead plaintiff deadline of July 6, 2026, emphasizing the need for investors to act to protect their claims.
- Legal Consultation Information: The Law Offices of Frank R. Cruz encourage investors who have suffered losses in these companies to contact them for legal rights information, ensuring they understand their options in the class actions to safeguard their interests.
See More
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against SES AI Corporation for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between January 29, 2025, and March 4, 2026, with a deadline to contact the firm by June 26, 2026.
- False Statement Allegations: The complaint alleges that SES made false and misleading statements throughout the class period, overstating the potential results of deals with companies lacking substantial operations, which misled investors and resulted in significant losses when the truth emerged.
- Market Reaction: Following the revelation of SES's misleading public statements, investor losses increased significantly, indicating serious deficiencies in the company's disclosure practices that could adversely affect its future stock performance.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to join the lawsuit to seek compensation, demonstrating a commitment to protecting shareholder rights.
See More
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against SES AI Corporation, specifically for investors who purchased securities between January 29, 2025, and March 4, 2026, urging them to contact the firm before the June 26, 2026 deadline to seek lead plaintiff status.
- Investor Rights Protection: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and potential claims, ensuring timely action can be taken.
- Class Action Progress: The firm reminds investors that a federal securities class action has been filed against SES AI, and investors must act before the deadline to protect their interests in the ongoing legal proceedings.
- Company Disclosure Impact: As a publicly traded company, SES AI faces legal challenges that could affect its stock price and investor confidence, and Faruqi & Faruqi's investigation aims to help investors understand the potential legal ramifications and their impact on investments.
See More
- Class Action Initiated: SES AI Corporation (NYSE: SES) faces a class action lawsuit from shareholders for making false statements between January 29, 2025, and March 4, 2026, with investors required to apply by June 26, 2026, to be lead plaintiffs, indicating significant legal risks that could tarnish the company's market reputation.
- False Statement Allegations: The complaint alleges that SES AI overstated its business prospects, particularly regarding expected results from deals with companies with limited operations, severely undermining investor confidence and potentially leading to further stock price declines.
- Financial Impact Revealed: SES disclosed on March 4, 2026, that logistics constraints delayed approximately $1.5 million in expected revenue from Q4 2025 to Q1 2026, directly affecting its revenue performance and highlighting operational deficiencies within the company.
- Stock Price Plummet: Following the lawsuit news, SES's stock price fell by $0.63, or 36.84%, closing at $1.08 per share on March 5, 2026, reflecting market pessimism regarding the company's future prospects and potentially shaking investor confidence further.
See More











